Inogen Net Interest Income vs Other Operating Expenses Analysis
INGN Stock | USD 8.48 0.17 2.05% |
Inogen financial indicator trend analysis is infinitely more than just investigating Inogen Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inogen Inc is a good investment. Please check the relationship between Inogen Net Interest Income and its Other Operating Expenses accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Net Interest Income vs Other Operating Expenses
Net Interest Income vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inogen Inc Net Interest Income account and Other Operating Expenses. At this time, the significance of the direction appears to have strong relationship.
The correlation between Inogen's Net Interest Income and Other Operating Expenses is 0.63. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Inogen Inc, assuming nothing else is changed. The correlation between historical values of Inogen's Net Interest Income and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Inogen Inc are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Net Interest Income i.e., Inogen's Net Interest Income and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.63 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Inogen Inc. It is also known as Inogen overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most indicators from Inogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. As of the 22nd of December 2024, Selling General Administrative is likely to grow to about 79 M, while Tax Provision is likely to drop about 740 K.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 176.5M | 153.5M | 126.7M | 116.2M | Total Revenue | 358.0M | 377.2M | 315.7M | 250.3M |
Inogen fundamental ratios Correlations
Click cells to compare fundamentals
Inogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 447.3M | 461.9M | 489.5M | 405.0M | 326.2M | 292.0M | |
Other Current Liab | 12.0M | 34.0M | 35.8M | 30.7M | 60.9M | 63.9M | |
Total Current Liabilities | 50.2M | 56.7M | 61.5M | 65.3M | 72.5M | 41.7M | |
Total Stockholder Equity | 344.6M | 349.6M | 370.2M | 297.4M | 204.8M | 222.6M | |
Property Plant And Equipment Net | 25.3M | 37.1M | 63.8M | 64.9M | 70.7M | 38.5M | |
Current Deferred Revenue | 5.5M | 7.0M | 8.6M | 8.9M | 8.0M | 4.7M | |
Net Debt | (191.3M) | (202.0M) | (208.9M) | (163.7M) | (103.6M) | (108.7M) | |
Retained Earnings | 81.4M | 75.6M | 69.3M | (14.5M) | (116.9M) | (111.1M) | |
Accounts Payable | 30.7M | 12.5M | 10.3M | 18.2M | 27K | 25.7K | |
Cash | 198.0M | 212.0M | 235.5M | 187.0M | 125.5M | 130.8M | |
Non Current Assets Total | 155.1M | 156.2M | 160.3M | 100.4M | 119.1M | 87.1M | |
Non Currrent Assets Other | 4.9M | 2.7M | 3.4M | 2.4M | 3.8M | 2.0M | |
Cash And Short Term Investments | 209.1M | 231.2M | 245.5M | 187.0M | 128.5M | 144.0M | |
Net Receivables | 37.3M | 31.8M | 25.8M | 64.4M | 42.2M | 31.3M | |
Common Stock Shares Outstanding | 22.2M | 22.0M | 22.5M | 22.9M | 23.2M | 22.7M | |
Liabilities And Stockholders Equity | 447.3M | 461.9M | 489.5M | 405.0M | 326.2M | 292.0M | |
Non Current Liabilities Total | 52.5M | 55.5M | 57.8M | 42.3M | 48.9M | 27.6M | |
Inventory | 35.7M | 24.8M | 31.9M | 34.1M | 21.8M | 19.9M | |
Other Current Assets | 10.2M | 17.9M | 26.0M | 19.2M | 14.5M | 8.7M | |
Other Stockholder Equity | 263.3M | 273.5M | 299.5M | 312.1M | 320.5M | 203.3M | |
Total Liab | 102.7M | 112.2M | 119.3M | 107.6M | 121.4M | 69.4M | |
Property Plant And Equipment Gross | 25.3M | 37.1M | 90.6M | 95.1M | 118.5M | 124.4M | |
Total Current Assets | 292.2M | 305.7M | 329.2M | 304.6M | 207.1M | 204.8M | |
Accumulated Other Comprehensive Income | (87K) | 475K | 1.5M | (243K) | 1.2M | 1.3M | |
Short Term Debt | 2.0M | 1.9M | 6.8M | 7.0M | 3.7M | 5.5M | |
Intangible Assets | 77.5M | 68.8M | 60.1M | 177K | 34.6M | 21.3M | |
Other Liab | 47.8M | 47.4M | 34.5M | 22.5M | 25.9M | 20.4M | |
Other Assets | 19.3M | 17.1M | 3.4M | 2.4M | 2.2M | 2.1M | |
Property Plant Equipment | 19.4M | 28.2M | 38.9M | 43.3M | 49.8M | 31.0M | |
Net Tangible Assets | 234.1M | 247.7M | 277.1M | 264.4M | 304.0M | 242.1M | |
Good Will | 33.0M | 33.2M | 33.0M | 32.9M | 10.1M | 16.1M | |
Retained Earnings Total Equity | 81.4M | 75.6M | 69.3M | (14.5M) | (16.7M) | (15.8M) | |
Short Term Investments | 43.7M | 11.1M | 19.3M | 10.0M | 3.0M | 2.8M | |
Deferred Long Term Liab | 9.8M | 232K | 87K | 25K | 22.5K | 21.4K | |
Capital Surpluse | 263.3M | 273.5M | 299.5M | 312.1M | 358.9M | 273.5M | |
Non Current Liabilities Other | 52.5M | 55.5M | 57.8M | 42.3M | 48.6M | 32.2M | |
Accumulated Depreciation | (44.9M) | (45.8M) | (51.7M) | (51.8M) | (46.7M) | (49.0M) |
Pair Trading with Inogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.Moving against Inogen Stock
0.4 | FIGS | Figs Inc | PairCorr |
0.33 | EW | Edwards Lifesciences Corp | PairCorr |
0.32 | EUDA | EUDA Health Holdings | PairCorr |
The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.
The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (2.25) | Revenue Per Share 14.095 | Quarterly Revenue Growth 0.058 | Return On Assets (0.1) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.